Paul Tudor Jones’s IN8bio INAB Stock Holding History

Paul Tudor Jones’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,110	Closed	-$434K	–	2692
2021 Q3	$434K	Buy	+2,110	New	+$525K	0.01%	1753

Other funds holding INAB

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Paul Tudor Jones's INAB Position: Q4 2021 in Review

Paul Tudor Jones sold out of IN8bio (INAB) in Q4 2021, closing a stake of 2,110 shares — an estimated $434K sold.

Paul Tudor Jones first reported a position in INAB in Q3 2021 and held it in 1 quarter. The position peaked at $434K in Q3 2021. 13 funds tracked by Wall St. Rank hold INAB as of Q4 2021.

Paul Tudor Jones reported no remaining IN8bio position as of Q4 2021 after selling out during the quarter.
Paul Tudor Jones sold 2,110 IN8bio shares in Q4 2021, an estimated $434K.
Paul Tudor Jones first reported a position in IN8bio in Q3 2021 and held it in 1 quarter.
Paul Tudor Jones's IN8bio position peaked at $434K in Q3 2021.
13 funds tracked by Wall St. Rank held IN8bio as of Q4 2021.

Based on Tudor Investment Corp's 13F filing for Q4 2021, filed 14 Feb 2022.